FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20240620E00430
1. Date of relevant event: 17/06/2024
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02269
4. Name of listed corporation: WuXi Biologics (Cayman) Inc. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 4,153,106,949
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Zhou
(Other names) Weichang
10. Name of director (Chinese): 周偉昌 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1316There has been a change in nature of your interest in the shares because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
2101Beneficial owner
 
2101Beneficial owner
 		 52,735         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position15,990,2340.39
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position15,990,2340.39
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position15,990,234
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
07/01/201606/01/2026HKD1USD0.167  10,596,000
Long position
4105Unlisted derivatives - Physically settled
15/03/201714/03/2027HKD1USD0.340  2,493,000
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
12/11/202212/11/2025      212,183
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
16/06/202316/06/2026      158,209
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
10/06/202410/06/2027      360,225
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
10/06/2023       298,416
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
24/08/202524/08/2028      241,642
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
24/08/202424/08/2025      325,385
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
21/11/202521/11/2028      132,484
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
21/11/202421/11/2025      278,223
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
27/03/202627/03/2029      411,048
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
   
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: The nature of interest in the shares of Dr. Zhou was changed due to a total of 52,735 RSUs granted under the share schemes of the Company being vested to him on 17/06/2024. 周博士的股票权益性质由于根据公司股份计划授予的52,735股受限制股份于2024年6月17日归属于他而发生了变化。
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded: 0
Date of filing this Form 3A: 20/06/2024
(dd/mm/yyyy)